Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
about
Effects of two anticholinergic drugs, trospium chloride and biperiden, on motility and evoked potentials of the oesophagusThe pharmacological treatment of urinary incontinence.Urinary incontinence in the elderly: part 3 of a series of articles on incontinenceChallenges in clinical applications of brain computer interfaces in individuals with spinal cord injury.Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinenceClinical pharmacology of old age syndromesMuscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderUrinary Urgency Medications May Compromise Discrete rather than Global Cognitive Skills.Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder.Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.Trospium chloride: the European experience.Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.New once-daily formulation for trospium in overactive bladder.Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.Anticholinergics for overactive bladder therapy: central nervous system effects.Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.Oxybutynin: past, present, and future.Cardiovascular effects of antimuscarinic agents in overactive bladder.Oxybutynin for treatment of nocturnal enuresis in children.Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system.Oxybutynin and its new transdermal application for the treatment of overactive bladder.Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.Tolterodine: a safe and effective treatment for older patients with overactive bladder.Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years."Wanting to be a good father": experiences of adolescent fathers of Mexican descent in a teen fathers program.Antimuscarinic agents in elderly people.Antimuscarinic drugs for the treatment of female urinary incontinence.Urinary incontinence: its assessment and relationship to depression among community-dwelling multiethnic older women.Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study
P2860
Q28287478-5FBF213F-03E7-4428-A1C0-7D77FB88DFE6Q33778812-0317CF0F-7FD6-4074-90E3-AF64C11D42DCQ34078299-BB72C74F-4AAB-4818-9B8B-DC208B1A5596Q34239264-053D6E54-A639-4B0A-A957-9CC7D7A06DDCQ35166683-D9DCDA2C-2360-4DBC-8BF8-89D38E0C6EE0Q35200049-A24B77D4-7809-4568-9AEB-D7DE538B6977Q35546189-4A9D5A2B-E8BE-441B-896F-8846EF8EE575Q36100621-543102DD-AE37-4B61-BDAF-67DA00DEF35DQ36192782-7099DA70-C901-4565-AFED-36DC2AFA13B1Q36395035-C8C2ACBA-5F65-40D5-A332-9754A821AC8BQ36521876-72E369E5-174E-4FC9-9BC5-06D6FC22D757Q37242704-FCA90DA9-5909-4047-952E-6718143E00D1Q37399563-4EA6764E-BD7E-4709-A179-8A461420AED5Q37789419-F2D95E80-D4B7-4227-89E4-BC4AE741930FQ37879017-02C6FE77-EC19-4981-806F-909339976D4AQ37954372-670B6FF8-6E9F-4D7B-A90F-B3CF2478DD5AQ37990531-7393E5FE-6F21-4DBC-96BE-8F521684B2FEQ38043396-CD680E64-4E78-4280-9325-0A3321A79CACQ38116972-1428E8FD-566D-4958-A0FB-18F03ACA5C05Q42091071-D5A624C0-B5FE-47C0-8F79-F4DD0BD1A2C0Q42545567-BE588970-FDE8-4CA4-9CD1-C362F0681ADBQ42651945-EEF97B05-FFA8-4E3C-9524-5D3A9D13DA90Q43267065-C8623893-8435-441C-8D7C-A2417FB72522Q43530511-A03E67EC-5F94-4870-8C40-018F77595557Q43674684-15A52660-D7B0-4623-8116-9407D2E7DBDEQ45243758-4DD57D60-CC39-4AC5-B7D4-398AF39FE33FQ50938578-4DD01007-75C5-49D8-9489-52C6C05B94E3Q51037347-EED6A7DD-BE44-471B-871F-91F73B7872D3Q51817526-E42902C9-E8A7-4D08-815B-FD892C79AFAFQ55496367-5344E65C-4CF6-491E-A12F-C2024711CE32Q58741609-5655EB93-10B3-4ECD-96A2-AB9DC748EFF5
P2860
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@en
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@nl
type
label
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@en
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@nl
prefLabel
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@en
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@nl
P2093
P356
P1476
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
@en
P2093
P Topfmeier
U Schwantes
P2888
P304
P356
10.1007/BF00191165
P577
1994-01-01T00:00:00Z